Concepedia

Oncolytic immunotherapy using recombinant vaccinia virus GLV-1h68 kills sorafenib-resistant hepatocellular carcinoma efficiently

Justin Ady, Jacqueline Heffner, Kelly Mojica, Clark Johnsen, Laurence J. Belin, Damon Love, Chin‐Tung Chen, Amudhan Pugalenthi, Elizabeth Klein, Nanhai G. Chen,

Surgery · 2014 · 25 citations · 23 references

Open access

Concepts

MedicineCancer BiologyOncologyImmunotherapyVaccinologyVirologyCancer ImmunotherapyOncogenic VirusesOncolytic Virus ImmunotherapyOncolytic Virus TherapyVaccine-based ImmunotherapyViral VaccinesOncolytic Viral TherapyOncolytic Viral VectorsOncolytic Virus VaccinesSorafenib TherapyVaccinia Virus VectorsViral EngineeringViral Vector Cancer Vaccines

References

23

Global cancer statistics

Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al. · New England Journal of Medicine · 2008 · 13K citations · Full text

Medicine, Oncology, Pharmacology +12

Management of Hepatocellular Carcinoma: An Update Δσ

Jordi Bruix, Morris Sherman · Hepatology · 2011 · 8.1K citations · Full text

Medicine, Internal Medicine, Oncology +14

Sorafenib in Advanced Hepatocellular Carcinoma

재연 정 · 2008 · 5.6K citations

Medicine, Oncology, Pharmacology +12

BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

Scott M. Wilhelm, Christopher Carter, LiYa Tang et al. · Cancer Research · 2004 · 4K citations · Full text

Medicine, Oncology, Pharmacology +17